Dr Daniel Krell, Consultant Oncologist

Dr Daniel Krell

Consultant Oncologist

Book online
|

Dr Daniel Krell MBChB BSc MRCP Dphil

Consultant Oncologist

MBChB BSc MRCP Dphil

Dr Daniel Krell

Consultant Oncologist MBChB BSc MRCP Dphil

Book online
|
MBChB BSc MRCP Dphil
Dr Daniel Krell, Oncologist

Dr Krell is a recommended Consultant Oncologist

Harley Street Clinic
LOC at Chelsea

Areas of expertise

  • Chemotherapy
  • Genetic testing
  • Biological therapy
  • Clinical trials
  • Immunotherapy
Harley Street Clinic
LOC at Chelsea

Recommendations for Dr Krell

These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.

1 GP
4 Specialists

Recommended by:

  • byDr Amit Majevadia, GP

    ❝Very approachable, great communication and would highly recommend Dr Krell for oncological care.❞

  • byProf. Giuseppe Kito Fusai, Consultant Hepato-Pancreato-Biliary Surgeon

    ❝I have the pleasure to recommend Dr Dan Krell, one of our best oncologists in the HPB Unit at the Royal Free Hospital. Dan is an excellent clinician with a specialist interest in Liver and Pancreato-Biliary cancer and he is involved in the various steps of the management of these patients, including pre and postoperative oncological treatments as well as palliative chemotherapy. His manners are exceptionally good which compliment a high level of proficiency.❞

  • byDr Steven Mann, Consultant Physician & Gastroenterologist

    ❝Dr Dan Krell is an experienced oncologist with excellent bedside manner and communication skills which parallels his knowledge and judgement. I respect his opinion and am grateful for his input into the care of our patients.❞

  • byMr Charles Imber, Consultant Hepatobiliary Pancreatic Surgeon

    ❝Highly recommend, thoroughly professional expert in his field.❞

  • by Dr Kalpesh Besherdas, Gastroenterologist

    ❝Dr Daniel Krell is an excellent communicator. He’s up-to-date in oncological treatment. He leads the upper GI cancer within our trust. I would recommend patients to him for upper gastrointestinal cancer treatment.❞

  • byDr Amit Majevadia, GP

    ❝Very approachable, great communication and would highly recommend Dr Krell for oncological care.❞

  • byProf. Giuseppe Kito Fusai, Consultant Hepato-Pancreato-Biliary Surgeon

    ❝I have the pleasure to recommend Dr Dan Krell, one of our best oncologists in the HPB Unit at the Royal Free Hospital. Dan is an excellent clinician with a specialist interest in Liver and Pancreato-Biliary cancer and he is involved in the various steps of the management of these patients, including pre and postoperative oncological treatments as well as palliative chemotherapy. His manners are exceptionally good which compliment a high level of proficiency.❞

  • byDr Steven Mann, Consultant Physician & Gastroenterologist

    ❝Dr Dan Krell is an experienced oncologist with excellent bedside manner and communication skills which parallels his knowledge and judgement. I respect his opinion and am grateful for his input into the care of our patients.❞

  • byMr Charles Imber, Consultant Hepatobiliary Pancreatic Surgeon

    ❝Highly recommend, thoroughly professional expert in his field.❞

  • by Dr Kalpesh Besherdas, Gastroenterologist

    ❝Dr Daniel Krell is an excellent communicator. He’s up-to-date in oncological treatment. He leads the upper GI cancer within our trust. I would recommend patients to him for upper gastrointestinal cancer treatment.❞

    • Make an appointment

    Address

    • The Harley Street Clinic

      35 Weymouth St, London, W1G 8BJ

    • LOC at Chelsea

      102 Sydney Street, Chelsea

    • Platinum Medical Centre

      15-17, Lodge Road, London, NW8 7JA

    • The Wellington Hospital

      St Johns Wood, London, NW8 7JA

    • Video consultation

      Online

    • LOC - Leaders in Oncology Care

      95 Harley Street, London, W1G 6AF

    About Dr Daniel Krell

    GMC number: 6075167

    Year qualified: 2003

    Place of primary qualification: University of Leeds

    Dr Daniel Krell is a consultant oncologist at the Royal Free Trust, specialising in gastro-oesophageal, colorectal, pancreatic, liver, and bile duct cancers, as well as neuroendocrine tumours. He is highly experienced in administering chemotherapy, targeted therapy, and immunotherapy. Dr Krell also manages patients with cancer of unknown primary and serves as the clinical lead for this area.

    Dr Krell is an integral member of the multidisciplinary team for gastro-oesophageal and hepatobiliary cancer at the Royal Free Trust. Additionally, he holds the position of clinical lead for neuroendocrine tumour oncology at The Royal Free Hospital.

    Dr Krell completed his oncology training at University College and the Royal Free Hospitals in London. He holds a primary medical degree, a Bachelor’s degree in immunology and microbiology, and a DPhil in Clinical Medicine from the University of Oxford’s Wellcome Trust Centre for Human Genetics. His research, funded by Cancer Research UK and HCA, focused on the role of genetic mutations in genes controlling cellular metabolism in cancer development, potentially identifying new therapeutic targets.

    Dr Krell remains actively involved in clinical research and trials aimed at discovering new cancer therapies, particularly for gastrointestinal, hepatobiliary, and neuroendocrine tumours. He has published numerous peer-reviewed papers and has presented his findings at both national and international conferences.

    He treats a variety of conditions, including:

    - Liver cancer
    - Biliary cancer
    - Bowel cancer
    - Colorectal cancer
    - Oesophageal cancer
    - Pancreatic cancer

    Dr Krell has been serving in his current roles since his appointment, bringing a wealth of knowledge and dedication to his patients and the medical community.

    Areas of expertise

    • Acute oncology
    • Adenocarcinoma
    • Bilary cancer
    • Bile duct cancer (cholangiocarcinoma)
    • Biological therapy
    • Bowel cancer
    • Cancer of unknown primary
    • Chemotherapy
    • Cholangiocarcinoma
    • Clinical trials
    • Colon cancer
    • Colorectal cancer
    • Gallbladder cancer
    • Gastric cancer
    • Gastrointestinal cancers
    • Gastrointestinal stromal tumour (GIST)
    • Gastro-oesophageal cancer
    • Genetic testing
    • Hepatocellular carcinoma
    • Immunotherapy
    • Liver cancer
    • Molecular genetic profiling
    • Neoadjuvant
    • Neuroendocrine cancer
    • Neuroendocrine tumours (NETS)
    • Oesophageal cancer
    • Pancreatic and biliary tract cancer
    • Rectal cancer
    • Small bowel cancer
    • Targeted therapy

    Professional memberships

    Royal College of Physicians
    General Medical Council

    Articles by Dr Daniel Krell

    Idh mutations in tumorigenesis and their potential role as novel therapeutic targets

    Idh mutations in tumorigenesis and their potential role as novel therapeutic targets

    Ongoing adjuvant/neoadjuvant trials in resectable metastatic colorectal cancer

    Ongoing adjuvant/neoadjuvant trials in resectable metastatic colorectal cancer

    Screen for idh1, idh2, idh3, d2hgdh and l2hgdh mutations in glioblastoma

    Screen for idh1, idh2, idh3, d2hgdh and l2hgdh mutations in glioblastoma

    Audit of ca125 follow-up after first-line therapy for ovarian cancer

    Audit of ca125 follow-up after first-line therapy for ovarian cancer

    Impact of effective prevention and management of febrile neutropenia

    Impact of effective prevention and management of febrile neutropenia

    Hot mutation screening in human glioblastomas

    Hot mutation screening in human glioblastomas

    Other specialists recommended by Dr Krell